Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine|June 27, 2022
Removal of the cervical collar from alpine rescue protocols? A biomechanical non-inferiority trial in real-life mountain conditionsGuillaume Grenier, Marc-Antoine Despatis, Karina Lebel, et al.
Current Opinion in Neurobiology|December 9, 2019
The microbiome-gut-brain axis in acute and chronic brain diseasesCorinne Benakis, Camille Martin-Gallausiaux, Jean-Pierre Trezzi, et al.
Drug and Alcohol Dependence|December 21, 2020
Alcohol consumption among French physicians: A cross-sectional studyPierre-Clément Thiebaud, Camille Martin, Diane Naouri, et al.
Applied and Environmental Microbiology|May 26, 2019
Glycoside Hydrolase Genes Are Required for Virulence of Agrobacterium tumefaciens on Bryophyllum daigremontiana and TomatoStephanie L Mathews, Haylea Hannah, Hillary Samagaio, et al.
Mabs|December 15, 2017
Antibody-drug conjugates: Design and development for therapy and imaging in and beyond cancer, LabEx MAbImprove industrial workshop, July 27-28, 2017, Tours, FranceCamille Martin, Claire Kizlik-Masson, André Pèlegrin, et al.
Scientific Reports|January 26, 2019
Identification of the novel role of butyrate as AhR ligand in human intestinal epithelial cellsLudovica Marinelli, Camille Martin-Gallausiaux, Jean-Marie Bourhis, et al.
Bioconjugate Chemistry|February 25, 2021
Innovative Bioconjugation Technology for Antibody-Drug Conjugates: Proof of Concept in a CD30-Positive Lymphoma Mouse ModelLudovic Juen, Christine B Baltus, Camille Gély, et al.
Scientific Reports|June 29, 2018
Butyrate produced by gut commensal bacteria activates TGF-beta1 expression through the transcription factor SP1 in human intestinal epithelial cellsCamille Martin-Gallausiaux, Fabienne Béguet-Crespel, Ludovica Marinelli, et al.
Cell Host & Microbe|September 15, 2022
SnapShot: The Expobiome MapVelma T E Aho, Marek Ostaszewski, Camille Martin-Gallausiaux, et al.
Bioconjugate Chemistry|February 1, 2022
Therapeutic Potential of MF-TTZ-MMAE, a Site-Specifically Conjugated Antibody-Drug Conjugate, for the Treatment of HER2-Overexpressing Breast CancerLudovic Juen, Christine B Baltus, Camille Gély, et al.
Pageof 4